Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal womenCarol J. Fabian, Stephen D. Hursting, Debra K. Sullivan et al.|Breast Cancer Research and Treatment|2013Cited by 63
Reduction in Ki-67 in Benign Breast Tissue of High-Risk Women with the Lignan Secoisolariciresinol DiglycosideCarol J. Fabian, Karen A. Johnson, Bruce F. Kimler et al.|Cancer Prevention Research|2010Cited by 50
Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trialQamar J. Khan, Carol J. Fabian, Bruce F. Kimler et al.|Breast Cancer Research and Treatment|2017Cited by 47
The association between cancer care coordination and quality of life is stronger for breast cancer patients with lower health literacy: A Greater Plains Collaborative studyBradley D. McDowell, Elizabeth A. Chrischilles, Jennifer R. Klemp et al.|Supportive Care in Cancer|2019Cited by 11
Effect of successful weight loss program on biomarkers for breast cancer in postmenopausal high-risk women.C. J. Fabian, Hung‐Wen Yeh, Jennifer R. Klemp et al.|Journal of Clinical Oncology|2010Cited by 4